Cargando…
Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments
Medullary thyroid carcinoma (MTC) arises from parafollicular cells in the thyroid gland, and although rare, it represents an aggressive type of thyroid cancer. MTC is recognized for its low mutational burden, with point mutations in RET or RAS genes being the most common oncogenic events. MTC can be...
Autores principales: | Martins, Rui Sousa, Jesus, Tito Teles, Cardoso, Luís, Soares, Paula, Vinagre, João |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381735/ https://www.ncbi.nlm.nih.gov/pubmed/37511745 http://dx.doi.org/10.3390/jpm13071132 |
Ejemplares similares
-
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
por: Prazeres, Hugo, et al.
Publicado: (2011) -
TERTmonitor—qPCR Detection of TERTp Mutations in Glioma
por: Brás, João Paulo, et al.
Publicado: (2023) -
Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”
por: Prazeres, Hugo, et al.
Publicado: (2016) -
Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017) -
Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)